Clinical Trials

Showing trials with last updates posted in 2026.

NCT07491172 | RECRUITING | PHASE1
90 participants

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2024-06-21
Completion:
2027-06-30
Conditions
  • Cardiovascular
  • Metabolic Disease
  • Dyslipidemias
  • Lipid Disorder
  • Hypertriglyceridemia
  • Heterozygous Familial Hypercholesterolemia (HeFH)
  • Homozygous Familial Hypercholesterolemia (HoFH)
  • Severe Hypertriglyceridemia (sHTG)
  • Mixed Hyperlipemia
  • Hypercholesterolaemia
Interventions
  • DRUG
No Results Yet
NCT07478848 | NOT_YET_RECRUITING | PHASE1
14 participants

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2026-05-27
Completion:
2029-01-01
Conditions
  • Large B Cell Lymphoma
  • Non Hodgkin Lymphoma (NHL)
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Diffuse Large B Cell Lymphoma Refractory
  • Diffuse Large B Cell Lymphoma Relapsed
Interventions
  • DRUG
  • RADIATION
  • BIOLOGICAL
No Results Yet
NCT07467772 | RECRUITING | PHASE2
30 participants

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2026-03-25
Completion:
2027-07-31
Conditions
  • Uterine Sarcoma
  • Uterine Leiomyosarcoma
  • Endometrial Stromal Sarcoma
  • ESS
  • Perivascular Epithelioid Cell Tumors
  • Uterine Adenosarcoma
  • Uterine PEComa
  • Estrogen Receptor Positive Tumor
  • uLMS
Interventions
  • DRUG
No Results Yet
NCT07457151 | RECRUITING
8 participants

Danicopan PMS in Korea

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-22
Start Date:
2026-04-10
Completion:
2028-06-27
Conditions
  • Paroxysmal Nocturnal Hemoglobinuria
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page